AGTR1 and Parkinson disease: The increase in pro-inflammatory cytokines due to the inflammatory process and other factors may contribute to the disruption of the BBB in PD patients; however, high levels of circulating AT1-AA may directly contribute to the disruption of the BBB [58,59,60], increasing BBB permeability to autoantibodies.